» Articles » PMID: 31544854

Controlling the Glycosylation Profile in MAbs Using Time-Dependent Media Supplementation

Overview
Date 2019 Sep 24
PMID 31544854
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In order to meet desired drug product quality targets, the glycosylation profile of biotherapeutics such as monoclonal antibodies (mAbs) must be maintained consistently during manufacturing. Achieving consistent glycan distribution profiles requires identifying factors that influence glycosylation, and manipulating them appropriately via well-designed control strategies. Now, the cell culture media supplement, MnCl, is known to alter the glycosylation profile in mAbs generally, but its effect, particularly when introduced at different stages during cell growth, has yet to be investigated and quantified. In this study, we evaluate the effect of time-dependent addition of MnCl on the glycan profile quantitatively, using factorial design experiments. Our results show that MnCl addition during the lag and exponential phases affects the glycan profile significantly more than stationary phase supplementation does. Also, using a novel computational technique, we identify various combinations of glycan species that are affected by this dynamic media supplementation scheme, and quantify the effects mathematically. Our experiments demonstrate the importance of taking into consideration the time of addition of these trace supplements, not just their concentrations, and our computational analysis provides insight into what supplements to add, when, and how much, in order to induce desired changes.

Citing Articles

N-Glycosylation modulators for targeted manipulation of glycosylation for monoclonal antibodies.

Gangwar N, Dixit N, Rathore A Appl Microbiol Biotechnol. 2025; 109(1):16.

PMID: 39841264 PMC: 11754368. DOI: 10.1007/s00253-025-13405-5.


Evaluating the impact of media and feed combinations on CHO cell culture performance and monoclonal antibody (trastuzumab) production.

Gyorgypal A, Chaturvedi A, Chopda V, Zhang H, Chundawat S Cytotechnology. 2025; 77(1):40.

PMID: 39803414 PMC: 11718031. DOI: 10.1007/s10616-024-00690-7.


Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture.

Saeki H, Fueki K, Maeda N Cytotechnology. 2024; 77(1):1.

PMID: 39568575 PMC: 11573942. DOI: 10.1007/s10616-024-00669-4.


Explainable AI for CHO cell culture media optimization and prediction of critical quality attribute.

Gangwar N, Balraj K, Rathore A Appl Microbiol Biotechnol. 2024; 108(1):308.

PMID: 38656382 PMC: 11043154. DOI: 10.1007/s00253-024-13147-w.


Effects of process intensification on homogeneity of an IgG1:κ monoclonal antibody during perfusion culture.

Liang G, Madhavarao C, Morris C, OConnor T, Ashraf M, Yoon S Appl Microbiol Biotechnol. 2024; 108(1):274.

PMID: 38530495 PMC: 10965650. DOI: 10.1007/s00253-024-13110-9.


References
1.
Kunkel J, Jan D, Jamieson J, Butler M . Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. J Biotechnol. 1998; 62(1):55-71. DOI: 10.1016/s0168-1656(98)00044-3. View

2.
Majid F, Butler M, Al-Rubeai M . Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2. Biotechnol Bioeng. 2006; 97(1):156-69. DOI: 10.1002/bit.21207. View

3.
Elvin J, Couston R, van der Walle C . Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int J Pharm. 2012; 440(1):83-98. DOI: 10.1016/j.ijpharm.2011.12.039. View

4.
Berger M, Kaup M, Blanchard V . Protein glycosylation and its impact on biotechnology. Adv Biochem Eng Biotechnol. 2011; 127:165-85. DOI: 10.1007/10_2011_101. View

5.
Grainger R, James D . CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation. Biotechnol Bioeng. 2013; 110(11):2970-83. DOI: 10.1002/bit.24959. View